TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IDYA

Ideaya Biosciences Inc

Healthcare · Biotechnology

37.40$ -1.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Ideaya Biosciences Inc (IDYA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,310 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IDYA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
533 649 962 974 1,240 1,124 1,101 1,041 1,185 1,109 1,030 1,310
482 533 709 713 932 690 708 686 803 667 696 864
152 157 108 183 400 84 130 115 299 113 158 273
469 525 699 702 920 676 693 670 787 639 671 829
6.7 0.0 0.0 0.0 0.0 0.0 – – – 6.0 6.6 15
-42 533 0.0 0.0 – – – – – – – –
25 28 26 42 59 65 77 82 93 86 93 111
25 27 25 41 41 46 51 55 65 59 65 83
2.1 1.7 1.2 0.6 – 0.3 0.3 0.3 0.3 0.3 0.4 1.2
5.2 6.6 6.3 16 13 15 18 17 18 18 21 31
508 621 935 932 1,180 1,059 1,024 960 1,092 1,023 937 1,199
-314 -348 -388 -441 -493 -623 -695 -773 -653 -737 -835 -948
60 65 75 78 86 87 88 88 90 89 89 92

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?